Wellborn, Kyle, Pilkinton, Fry, PC Provides Plasma Technologies, Inc. $2 Million in Support of Drexel's Plasma Sterilizer Technology

CORPUS CHRISTI, Texas, Nov. 18, 2010 /PRNewswire/ -- Plasma Technologies, Inc., a Texas corporation, has entered into an agreement with Wellborn, Kyle, Pilkinton, Fry, PC, a Texas-based corporation, giving it rights to distribute the Plasma NO device in Mexico and South America. As a part of this agreement Plasma Technologies, Inc. has received $1 million in equity funding and $1 million in distribution fees from Wellborn, Kyle, Pilkinton, Fry, PC.  The $2 million in funding and fees will be used to further the research, development and commercialization of Plasma Sterilizer technology developed by A. J. Drexel Plasma Institute and Drexel's School of Biomedical Engineering, Science and Health Systems, and licensed by Drexel University to Plasma Technologies, Inc.

"It is indeed a privilege to become a part of Plasma Technologies, Inc. and its far-reaching technologies. We at Wellborn, Kyle, Pilkinton, Fry PC hold Plasma Technologies and its staff in high esteem," said Chief Bear, Director of Wellborn, Kyle, Pilkinton, Fry PC. "With our established network in Mexico, Central and South America, we feel sure that Plasma Technologies, Inc. will be a dominant force in the medical plasma market."

"We are excited to have Wellborn, Kyle, Pilkinton, Fry, PC as equity partners," said Bert Quintanilla, Vice President of Community and Governmental Relations. "The funding and partnership provide Plasma Technologies, Inc. with the necessary resources to commercialize Plasma Sterilizer and Plasma NO technologies. Plasma Sterilizer applications will enable sterilization of bacteria such as MRSA and E Coli on living tissue and Plasma NO will promote quicker healing of living tissue."

About Wellborn, Kyle, Pilkinton, Fry, PC:

Wellborn, Kyle, Pilkinton, Fry, PC is an International Consulting firm created for financing of commercial projects, strategic planning and development of commercial projects.

About A. J. Drexel Plasma Institute:

Created in 2002 and highly recognized as a plasma engineering center worldwide, the Institute researches fundamental and applied aspects of plasma in three major directions, 1) plasma energy systems, including fuel conversion, hydrogen production, green energy and ignition and combustion control 2) plasma medicine: direct plasma treatment of wounds, burns and diseases, and plasma sterilization of medical instruments and hospital environments and 3) plasma environmental control: plasma in water cleaning, air treatment, material processing and environmental control. Faculty from across the University are involved in the interdisciplinary research.  

About Drexel University's School of Biomedical Engineering, Science and Health Systems:

The School offers an undergraduate degree in biomedical engineering and graduate (master's and doctoral) degrees in biomedical engineering and biomedical sciences. The students and faculty of the School are committed to move their discoveries from laboratories to clinical practice. The School enjoys a strong entrepreneurship program in biomedical technologies in alliance with regional economic development agencies, corporations and alumni, together with advisors from the business development, legal and investment communities.

SOURCE Drexel University